The Effects of Mindfulness-Based Stress Reduction on Attention and Pain-related Symptoms in Chronic Pain Patients
- Conditions
- Pain
- Interventions
- Behavioral: Mindfulness-Based Stress Reduction
- Registration Number
- NCT01487473
- Lead Sponsor
- York University
- Brief Summary
The main purpose of this study is to determine the degree to which Mindfulness-Based Stress Reduction, a group-based psychological therapy that includes mindfulness meditation exercises, reduces depression, anxiety, stress, pain intensity, and interference of pain with daily life among adult chronic pain patients.
The second purpose is to examine the role of attention in improving psychological and physical health for chronic pain patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 49
- Adult chronic pain patients who are proficient in English
- Capable of interacting with others in a group setting
- Capable of working with a computer
- Alcohol or drug abuse (past history is acceptable as long as their situation has been stable for at least 3 months)
- Psychiatric psychosis (patients who have a past history of schizophrenia are eligible as long as they are currently stable)
- Current major depressive disorder
- Current severe social phobia
- At immediate risk for suicide
- Cerebral lesions or tumors (unless medically and cognitively stable)
- Neurological disease
- Medically unstable
- Cognitively unstable
- Previously participated in a mindfulness meditation program
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Mindfulness-Based Stress Reduction Mindfulness-Based Stress Reduction -
- Primary Outcome Measures
Name Time Method Pain disability and Attention Baseline, immediately following treatment, and at 3 months follow up Change in pain disability assessed by the Pain Disability Index (PDI).
Change in attention assessed by an adapted version of the Change Blindness Task
- Secondary Outcome Measures
Name Time Method Stress Baseline, immediately following treatment, and at 3 months follow up Change in stress assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21)
Acceptance Baseline, immediately following treatment, and at 3 months follow up Change in acceptance assessed by the Chronic Pain Acceptance Questionnaire (CPAQ)
Pain Intensity Baseline, immediately following treatment, and at 3 months follow up Change in pain intensity assessed by the Short-form McGill Pain Questionnaire (SF-MPQ-2).
Depression Baseline, immediately following treatment, and at 3 months follow up Change in depression assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21)
Anxiety Baseline, immediately following treatment, and at 3 months follow up Change in anxiety assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21)
Mindfulness Baseline, immediately following treatment, and at 3 months follow up Change in mindfulness assessed by the Five Facet Mindfulness Questionnaire (FFMQ) and Mindful Attention Awareness Scale (MAAS)
Trial Locations
- Locations (1)
Mount Sinai Hospital
🇨🇦Toronto, Ontario, Canada